메뉴 건너뛰기




Volumn 358, Issue 24, 2008, Pages 2545-2559

Effects of intensive glucose lowering in type 2 diabetes

(1,093)  Gerstein, Hertzel C a,j,ch   Miller, M E b   Byington, Robert P b   Goff, D C b   Bigger, J T ch   Buse, J B ch   Cushman, W C e,ch   Genuth, S f   Ismail Beigi, Faramarz f,am,ap   Grimm, Richard H g   Probstfield, J L h,ch   Simons Morton, D G i,ch   Friedewald, William T c   Gotto, A M ch   Bailey, K ch   Gohdes, D ch   Haffner, S ch   Hiss, R ch   Jamerson, K ch   Lee, K ch   more..


Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA GLUCOSIDASE INHIBITOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; EXENDIN 4; FENOFIBRATE; GLIMEPIRIDE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PLACEBO; REPAGLINIDE; ROSIGLITAZONE; SIMVASTATIN; THIAZIDE DIURETIC AGENT;

EID: 45149131667     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa0802743     Document Type: Article
Times cited : (6965)

References (25)
  • 1
    • 34250694096 scopus 로고    scopus 로고
    • Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: Current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
    • Goff DC Jr, Gerstein HC, Ginsberg HN, et al. Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 2007;99:4i-20i.
    • (2007) Am J Cardiol , vol.99
    • Goff Jr, D.C.1    Gerstein, H.C.2    Ginsberg, H.N.3
  • 2
    • 4644351335 scopus 로고    scopus 로고
    • Meta-analysis: Glycosylated hemoglobin and cardiovascular disease in diabetes mellitus
    • Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 2004;141:421-31.
    • (2004) Ann Intern Med , vol.141 , pp. 421-431
    • Selvin, E.1    Marinopoulos, S.2    Berkenblit, G.3
  • 3
    • 24944482507 scopus 로고    scopus 로고
    • The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: A prospective epidemiological analysis
    • Gerstein HC, Pogue J, Mann JF, et al. The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis. Diabetologia 2005;48:1749-55.
    • (2005) Diabetologia , vol.48 , pp. 1749-1755
    • Gerstein, H.C.1    Pogue, J.2    Mann, J.F.3
  • 4
    • 0034641568 scopus 로고    scopus 로고
    • Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
    • Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.
    • (2000) BMJ , vol.321 , pp. 405-412
    • Stratton, I.M.1    Adler, A.I.2    Neil, H.A.3
  • 5
    • 40249120466 scopus 로고    scopus 로고
    • Standards of medical care in diabetes - 2008
    • American Diabetes Association
    • American Diabetes Association. Standards of medical care in diabetes - 2008. Diabetes Care 2008;31:Suppl 1:S12-S54.
    • (2008) Diabetes Care , vol.31 , Issue.SUPPL. 1
  • 6
    • 0347867354 scopus 로고    scopus 로고
    • Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee
    • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2003;23:Suppl 2:S1-S152.
    • (2003) Can J Diabetes , vol.23 , Issue.SUPPL. 2
  • 7
    • 33846414720 scopus 로고    scopus 로고
    • Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary
    • Rydén L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. Eur Heart J 2007;28:88-136.
    • (2007) Eur Heart J , vol.28 , pp. 88-136
    • Rydén, L.1    Standl, E.2    Bartnik, M.3
  • 8
    • 77649091668 scopus 로고    scopus 로고
    • American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus
    • AACE Diabetes Mellitus Clinical Practice Guidelines Task Force
    • AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007;13:Suppl 1:1-68.
    • (2007) Endocr Pract , vol.13 , Issue.SUPPL. 1 , pp. 1-68
  • 9
    • 34250785602 scopus 로고    scopus 로고
    • Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: Design and methods
    • Buse JB, Bigger JT, Byington RP, et al. Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol 2007;99:21i-33i.
    • (2007) Am J Cardiol , vol.99
    • Buse, J.B.1    Bigger, J.T.2    Byington, R.P.3
  • 10
    • 34250714841 scopus 로고    scopus 로고
    • Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
    • Gerstein HC, Riddle MC, Kendall DM, et al. Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 2007;99:34i-43i.
    • (2007) Am J Cardiol , vol.99
    • Gerstein, H.C.1    Riddle, M.C.2    Kendall, D.M.3
  • 11
    • 34250753275 scopus 로고    scopus 로고
    • Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
    • Ginsberg HN, Bonds DE, Lovato LC, et al. Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 2007;99:56i-67i.
    • (2007) Am J Cardiol , vol.99
    • Ginsberg, H.N.1    Bonds, D.E.2    Lovato, L.C.3
  • 12
    • 34250704187 scopus 로고    scopus 로고
    • Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
    • Bonds DE, Kurashige EM, Bergenstal R, et al. Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 2007;99:80i-89i.
    • (2007) Am J Cardiol , vol.99
    • Bonds, D.E.1    Kurashige, E.M.2    Bergenstal, R.3
  • 13
    • 85031385654 scopus 로고    scopus 로고
    • ACCORD Web site. (Accessed May 19, 2008, at http://www.accordtrial.org.)
    • ACCORD Web site. (Accessed May 19, 2008, at http://www.accordtrial.org.)
  • 14
    • 34250786787 scopus 로고    scopus 로고
    • Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
    • Kingry C, Bastien A, Booth G, et al. Recruitment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 2007;99:68i-79i.
    • (2007) Am J Cardiol , vol.99
    • Kingry, C.1    Bastien, A.2    Booth, G.3
  • 15
    • 0032511583 scopus 로고    scopus 로고
    • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53. [Erratum, Lancet 1999;354: 602.]
    • UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53. [Erratum, Lancet 1999;354: 602.]
  • 16
    • 0031018291 scopus 로고    scopus 로고
    • Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial: Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes
    • Abraira C, Colwell JA, Nuttall F, et al. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial: Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med 1997;157:181-8.
    • (1997) Arch Intern Med , vol.157 , pp. 181-188
    • Abraira, C.1    Colwell, J.A.2    Nuttall, F.3
  • 17
    • 0014914649 scopus 로고
    • A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results
    • Meinert CL, Knatterud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 1970;19:Suppl:789-830.
    • (1970) Diabetes , vol.19 , Issue.SUPPL. , pp. 789-830
    • Meinert, C.L.1    Knatterud, G.L.2    Prout, T.E.3    Klimt, C.R.4
  • 18
    • 0030048984 scopus 로고    scopus 로고
    • Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus
    • Genuth S. Exogenous insulin administration and cardiovascular risk in non-insulin-dependent and insulin-dependent diabetes mellitus. Ann Intern Med 1996;124:104-9.
    • (1996) Ann Intern Med , vol.124 , pp. 104-109
    • Genuth, S.1
  • 19
    • 33745400514 scopus 로고    scopus 로고
    • Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: A population-based retrospective cohort study
    • Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet 2006;368:29-36.
    • (2006) Lancet , vol.368 , pp. 29-36
    • Booth, G.L.1    Kapral, M.K.2    Fung, K.3    Tu, J.V.4
  • 20
    • 0037463674 scopus 로고    scopus 로고
    • Trends in the mortality burden associated with diabetes mellitus: A population-based study in Rochester, Minn, 1970-1994
    • Thomas RJ, Palumbo PJ, Melton LJ III, et al. Trends in the mortality burden associated with diabetes mellitus: a population-based study in Rochester, Minn, 1970-1994. Arch Intern Med 2003;163:445-51.
    • (2003) Arch Intern Med , vol.163 , pp. 445-451
    • Thomas, R.J.1    Palumbo, P.J.2    Melton III, L.J.3
  • 21
    • 0142199812 scopus 로고    scopus 로고
    • Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial
    • Abraira C, Duckworth W, McCarren M, et al. Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial. J Diabetes Complications 2003;17:314-22.
    • (2003) J Diabetes Complications , vol.17 , pp. 314-322
    • Abraira, C.1    Duckworth, W.2    McCarren, M.3
  • 22
    • 17944382481 scopus 로고    scopus 로고
    • Study rationale and design of ADVANCE: action in diabetes and vascular disease - preterax and diamicron MR controlled evaluation. Diabetologia 2001;44:1118-20
    • Study rationale and design of ADVANCE: action in diabetes and vascular disease - preterax and diamicron MR controlled evaluation. Diabetologia 2001;44:1118-20.
  • 23
    • 14644427785 scopus 로고    scopus 로고
    • Hyperglycemia and its effect after acute myocardial infarction on cardiovascular outcomes in patients with Type 2 diabetes mellitus (HEART2D) Study design
    • Milicevic Z, Raz I, Strojek K, et al. Hyperglycemia and its effect after acute myocardial infarction on cardiovascular outcomes in patients with Type 2 diabetes mellitus (HEART2D) Study design. J Diabetes Complications 2005;19:80-7.
    • (2005) J Diabetes Complications , vol.19 , pp. 80-87
    • Milicevic, Z.1    Raz, I.2    Strojek, K.3
  • 24
    • 36749121985 scopus 로고    scopus 로고
    • Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: The ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention)
    • ORIGIN Trial Investigators
    • ORIGIN Trial Investigators, Gerstein H, Yusuf S, Riddle MC, Ryden L, Bosch J. Rationale, design, and baseline characteristics for a large international trial of cardiovascular disease prevention in people with dysglycemia: the ORIGIN Trial (Outcome Reduction with an Initial Glargine Intervention). Am Heart J 2008;155:26-32.
    • (2008) Am Heart J , vol.155 , pp. 26-32
    • Gerstein, H.1    Yusuf, S.2    Riddle, M.C.3    Ryden, L.4    Bosch, J.5
  • 25
    • 33745265251 scopus 로고    scopus 로고
    • Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial
    • Magee MF, Isley WL. Rationale, design, and methods for glycemic control in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Am J Cardiol 2006;97:20G-30G.
    • (2006) Am J Cardiol , vol.97
    • Magee, M.F.1    Isley, W.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.